# Rifabutin Versus Rifampicin for Treatment of Staphylococcal PJI Treated With DAIR

> **NCT04672525** · PHASE3 · RECRUITING · sponsor: **Tourcoing Hospital** · enrollment: 436 (estimated)

## Conditions studied

- Prosthetic Infection

## Interventions

- **DRUG:** Rifabutin
- **DRUG:** Rifampicin

## Key facts

- **NCT ID:** NCT04672525
- **Lead sponsor:** Tourcoing Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2021-11-08
- **Primary completion:** 2026-11
- **Final completion:** 2027-06
- **Target enrollment:** 436 (ESTIMATED)
- **Last updated:** 2022-05-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04672525

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04672525, "Rifabutin Versus Rifampicin for Treatment of Staphylococcal PJI Treated With DAIR". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04672525. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*